Headquarters: Epalinges, Switzerland
EUR as of July 1, 2023
|Company||Market Cap (USD)|
|Zoetis Inc.||$78.54 B|
|MERCK Kommanditgesellschaft auf Aktien||$70.69 B|
|Takeda Pharmaceutical Company Limited||$46.59 B|
|Haleon plc||$37.99 B|
|Eisai Co. Ltd||$17.26 B|
Elanix Biotechnologies AG, a tissue regeneration company, develops and commercializes products for acute wound care, dermatological, and gynecological applications, and provides cell technology services. It also owns cell banks containing various quantities of cells. The company was founded in 1966 and is headquartered in Epalinges, Switzerland.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!